Jillian K McCabe,Hilary R Keller,Melanie Goldfarb
Jillian K McCabe
A long lifetime of survivorship for thyroid patients with cancer lends it to unique healthcare-related concerns and quality-of-life issues. Thyroid cancer survivors report decreased health-care related quality-of-life (HRQOL) than survivors...
Cord Sturgeon
Cord Sturgeon
In the United States, chronic health conditions are commonly associated with financial burden and resultant financial toxicity. Although the problem is widespread, financial burden is not evenly distributed in the United States. Cancer surv...
Amanda La Greca,Bryan Haugen
Amanda La Greca
Medullary thyroid carcinoma (MTC) is a rare form of thyroid cancer that has different treatment approaches than differentiated thyroid cancer. MTC can be a challenge to diagnose by ultrasound imaging and fine-needle aspiration, so it should...
External Beam Radiation Therapy for Thyroid Cancer: Modes of Administration and Current Role [0.03%]
甲状腺癌的外部放射治疗：给药方式和当前角色分析
Peter H Ahn
Peter H Ahn
Radiation therapy in one form or the other has an important role in the treatment of thyroid cancer. In the definitive setting, external beam radiation therapy is used in situations where microscopic or gross residual disease after thyroide...
An Update on Redifferentiation Therapy for Radioiodine Refractory Thyroid Cancer [0.03%]
分化型甲状腺癌放射性碘难治性复发的治疗进展
Laura Boucai
Laura Boucai
Two-thirds of patients with advanced thyroid cancer are refractory to radioactive iodine (RAI). Inhibition of genetic drivers of thyroid cancer in the intracellular mitogen-activated protein kinase pathway, like BRAF, RAS, RET, and NTRK, re...
Dosimetry in Advanced Thyroid Cancer: A Piece of a Puzzle? [0.03%]
分化型甲状腺癌复发转移患者的放射性碘清甲和清灶治疗：复杂 puzzle 的重要环节吗？
Carmela Nappi,Yann Cras,Livia Lamartina et al.
Carmela Nappi et al.
Thyroid cancer demonstrates variable prognosis depending on disease severity with low-risk tumors showing excellent survival rates and high-risk cases facing poorer outcomes. Radioactive iodine therapy is the standard treatment. However, in...
The Evolving Role of Radioactive Iodine in Thyroid Cancer Diagnosis and Treatment [0.03%]
放射性碘在甲状腺癌诊断和治疗中的作用及其演变
Kanchan Kulkarni,Anca M Avram
Kanchan Kulkarni
The authors summarize the evolving role of radioiodine therapy in differentiated thyroid carcinoma with focus on indications for radioiodine therapy, careful selection, risk-based therapy approach, and treatment of locally-advanced and dist...
David Z Allen,Mark Zafereo
David Z Allen
With tumor molecular discoveries, novel therapeutics, and innovative intraoperative technologies, there has been rapid change and progress in thyroid oncology. Molecular genetic testing of thyroid neoplasms, parathyroid autofluorescence, re...
Sarah Hamidi,Anastasios Maniakas,Maria E Cabanillas
Sarah Hamidi
In 2025, it is no longer appropriate to view anaplastic thyroid cancer (ATC) patients with the sense of nihilism and hopelessness characteristic of the approach used in past decades. Early, rapid somatic genomic testing to determine BRAF (v...
Benjamin J Gigliotti,Anna-Karoline Israel,Timothy B Winslow et al.
Benjamin J Gigliotti et al.
Follicular thyroid cancer is an uncommon well-differentiated thyroid cancer with a wide spectrum of behavior, ranging from indolent minimally invasive tumors to extensive angioinvasive tumors with distant metastasis. While often grouped wit...